To test the relevance of DRD3 signalling on CD8+ T-cells in the anti-tumour response, a mouse model of melanoma was induced in mice bearing Drd3-sufficient or Drd3-deficient tumour-specific CD8+ T-cells. Here, DRD3 is linked to neoplasm.